Wyde PR - Search Results

1

Chimeric coronavirus-like particles carrying severe acute respiratory syndrome coronavirus (SCoV) S protein protect mice against challenge with SCoV.

Lokugamage KG, Yoshikawa-Iwata N, Ito N, Watts DM, Wyde PR, Wang N, Newman P, Kent Tseng CT, Peters CJ, Makino S. Lokugamage KG, et al. Among authors: wyde pr. Vaccine. 2008 Feb 6;26(6):797-808. doi: 10.1016/j.vaccine.2007.11.092. Epub 2007 Dec 26. Vaccine. 2008. PMID: 18191004 Free PMC article.

2

Evaluation of cotton rats as a model for severe acute respiratory syndrome.

Watts DM, Peters CJ, Newman P, Wang N, Yoshikawa N, Tseng CK, Wyde PR. Watts DM, et al. Among authors: wyde pr. Vector Borne Zoonotic Dis. 2008 Jun;8(3):339-44. doi: 10.1089/vbz.2007.0210. Vector Borne Zoonotic Dis. 2008. PMID: 18447621 Free PMC article.

3

Evaluation of the immunogenicity and protective efficacy of a candidate parainfluenza virus type 3 subunit vaccine in cotton rats.

Ambrose MW, Wyde PR, Ewasyshyn M, Bonneau AM, Caplan B, Meyer HL, Klein M. Ambrose MW, et al. Among authors: wyde pr. Vaccine. 1991 Jul;9(7):505-11. doi: 10.1016/0264-410x(91)90037-7. Vaccine. 1991. PMID: 1654680

4

Enhancement of the protective efficacy of inactivated influenza A virus vaccine in aged mice by IL-2 liposomes.

Mbawuike IN, Wyde PR, Anderson PM. Mbawuike IN, et al. Among authors: wyde pr. Vaccine. 1990 Aug;8(4):347-52. doi: 10.1016/0264-410x(90)90093-2. Vaccine. 1990. PMID: 1697721

5

Immunogenicity and efficacy of orally administered inactivated influenza virus vaccine in mice.

Farag-Mahmod FI, Wyde PR, Rosborough JP, Six HR. Farag-Mahmod FI, et al. Among authors: wyde pr. Vaccine. 1988 Jun;6(3):262-8. doi: 10.1016/0264-410x(88)90222-8. Vaccine. 1988. PMID: 3420975

6

Enhanced pulmonary pathology associated with the use of formalin-inactivated respiratory syncytial virus vaccine in cotton rats is not a unique viral phenomenon.

Piedra PA, Wyde PR, Castleman WL, Ambrose MW, Jewell AM, Speelman DJ, Hildreth SW. Piedra PA, et al. Among authors: wyde pr. Vaccine. 1993 Nov;11(14):1415-23. doi: 10.1016/0264-410x(93)90170-3. Vaccine. 1993. PMID: 7508665

7

Protection of mice against lethal viral infection by synthetic peptides corresponding to B- and T-cell recognition sites of influenza A hemagglutinin.

Simeckova-Rosenberg J, Yun Z, Wyde PR, Atassi MZ. Simeckova-Rosenberg J, et al. Among authors: wyde pr. Vaccine. 1995 Jul;13(10):927-32. doi: 10.1016/0264-410x(95)00014-r. Vaccine. 1995. PMID: 7483766

8

Contrasting effects of type I interferon as a mucosal adjuvant for influenza vaccine in mice and humans.

Couch RB, Atmar RL, Cate TR, Quarles JM, Keitel WA, Arden NH, Wells J, Niño D, Wyde PR. Couch RB, et al. Among authors: wyde pr. Vaccine. 2009 Aug 27;27(39):5344-8. doi: 10.1016/j.vaccine.2009.06.084. Epub 2009 Jul 14. Vaccine. 2009. PMID: 19607949 Free PMC article. Clinical Trial.

9

Infection of leucocytes by measles vaccine viruses Edmonston-Zagreb and Enders-Moraten has different consequences: potential mechanism for increased vaccine efficacy or aberrant activity in field trials.

Wyde PR, Attibele NR, Kemp WL. Wyde PR, et al. Vaccine. 1994 Jun;12(8):715-22. doi: 10.1016/0264-410x(94)90221-6. Vaccine. 1994. PMID: 8091849

10

Use of cotton rats for preclinical evaluation of measles vaccines.

Wyde PR, Stittelaar KJ, Osterhaus AD, Guzman E, Gilbert BE. Wyde PR, et al. Vaccine. 2000 Aug 15;19(1):42-53. doi: 10.1016/s0264-410x(00)00151-1. Vaccine. 2000. PMID: 10924785

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

88 results

Search Page

Filters